Literature DB >> 25169739

A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls.

Claudia Landi1, Elena Bargagli, Alfonso Carleo, Laura Bianchi, Assunta Gagliardi, Antje Prasse, Maria G Perari, Rosa M Refini, Luca Bini, Paola Rottoli.   

Abstract

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a devastating interstitial lung disease characterized by progressive loss of the alveolar integrity, recruitment, and activation of myofibroblast, and excessive collagen deposition that resulted in loss of parenchymal architecture and lung function. Although etiology is unknown, major risk factor of disease development is represented by cigarette smoke or exposure to dust. AIMS: Aim of this proteomic study was to compare broncho alveolar lavage fluid protein profiles of IPF patients, never-smoker healthy control (nonsmoker control) and smoker control subjects in order to investigate proteins potentially related to disease progression and pathogenesis.
METHODS: Broncho alveolar lavage fluid samples were resolved using 2D-PAGE and the differentially expressed proteins were identified by MS. The performed PCA statistically proved the correlation existing between differentially expressed spots in the three groups. Functional analysis of the identified proteins was performed by pathway and enrichment analysis by MetaCore and Database for Annotation, Visualization and Integrated Discovery.
RESULTS: Interestingly, transcriptional factors NF-kB, PPARγ, and c-myc emerged as well as a group of functional hubs. Enrichment analysis suggested that Gene Ontology (GO) process networks and pathway maps involved in IPF included angiotensin system maturation, renin-angiotensin-aldosteron system, heme metabolism, coagulation system, response to hypoxia, oxidative stress, and iron transport.
CONCLUSION: In conclusion, the combination of proteomic data with system biology platforms allowed us to amplify the information obtained processing the results and indicated the principal pathways involved. These information can point to potential biomarkers and new therapeutic targets opening the way for further analysis.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  2DE; Bronchoalveolar lavage; Functional analysis; Idiopathic pulmonary fibrosis; MS; Smoke

Mesh:

Substances:

Year:  2014        PMID: 25169739     DOI: 10.1002/prca.201400001

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  18 in total

1.  A proteomics approach to identifying key protein targets involved in VEGF inhibitor mediated attenuation of bleomycin-induced pulmonary fibrosis.

Authors:  Yogesh M Kulkarni; Sucharita Dutta; Anand Krishnan V Iyer; Rajkumar Venkatadri; Vivek Kaushik; Vani Ramesh; Clayton A Wright; Oliver John Semmes; Juan S Yakisich; Neelam Azad
Journal:  Proteomics       Date:  2015-11-24       Impact factor: 3.984

2.  Idiopathic pulmonary fibrosis a rare disease with severe bone fragility.

Authors:  Carla Caffarelli; Stefano Gonnelli; Maria Dea Tomai Pitinca; Valentina Francolini; Annalisa Fui; Elena Bargagli; Rosa Metella Refini; David Bennett; Ranuccio Nuti; Paola Rottoli
Journal:  Intern Emerg Med       Date:  2016-07-08       Impact factor: 3.397

Review 3.  Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis.

Authors:  Paolo Cameli; Alfonso Carleo; Laura Bergantini; Claudia Landi; Antje Prasse; Elena Bargagli
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

4.  Comparative Proteomic Analysis of Rat Bronchoalveolar Lavage Fluid after Exposure to Zinc Oxide Nanoparticles.

Authors:  Yu-Min Juang; Han-Ju Chien; Cheng-Yu Yang; Hsiao-Chien Yeh; Tsun-Jen Cheng; Chien-Chen Lai
Journal:  Mass Spectrom (Tokyo)       Date:  2017-03-24

5.  A novel seven-gene risk profile in BALF to identify high-risk patients with idiopathic pulmonary fibrosis.

Authors:  Ziliang Hou; Dan Peng; Jingjing Yang; Shuai Zhang; Jinxiang Wang
Journal:  J Thorac Dis       Date:  2022-05       Impact factor: 3.005

6.  Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach.

Authors:  Miriana d'Alessandro; Piera Soccio; Laura Bergantini; Paolo Cameli; Giulia Scioscia; Maria Pia Foschino Barbaro; Donato Lacedonia; Elena Bargagli
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

7.  The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes.

Authors:  David N O'Dwyer; Katy C Norman; Meng Xia; Yong Huang; Stephen J Gurczynski; Shanna L Ashley; Eric S White; Kevin R Flaherty; Fernando J Martinez; Susan Murray; Imre Noth; Kelly B Arnold; Bethany B Moore
Journal:  Sci Rep       Date:  2017-04-25       Impact factor: 4.379

8.  Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung Cancer.

Authors:  Ana Sofia Carvalho; Célia Marina Cuco; Carla Lavareda; Francisco Miguel; Mafalda Ventura; Sónia Almeida; Paula Pinto; Tiago Tavares de Abreu; Luís Vaz Rodrigues; Susana Seixas; Cristina Bárbara; Mikel Azkargorta; Felix Elortza; Júlio Semedo; John K Field; Leonor Mota; Rune Matthiesen
Journal:  Sci Rep       Date:  2017-02-07       Impact factor: 4.379

9.  Proteome Characterization of BALF Extracellular Vesicles in Idiopathic Pulmonary Fibrosis: Unveiling Undercover Molecular Pathways.

Authors:  Enxhi Shaba; Claudia Landi; Alfonso Carleo; Lorenza Vantaggiato; Eugenio Paccagnini; Mariangela Gentile; Laura Bianchi; Pietro Lupetti; Elena Bargagli; Antje Prasse; Luca Bini
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

10.  Proteomics and metabonomics analyses of Covid-19 complications in patients with pulmonary fibrosis.

Authors:  Jianrong Yang; Chunxia Chen; Wan Chen; Luying Huang; Zhao Fu; Kun Ye; Liwen Lv; Zhihuang Nong; Xing Zhou; Wensheng Lu; Mei Zhong
Journal:  Sci Rep       Date:  2021-07-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.